Is serum amyloid A elevated in the serum of lung cancer patients with poor prognosis?
There are several functions of the SAA protein, described in the context of inflammation, that are compatible with the mechanism of tumour invasion and metastasis. Our study not only detected increased SAA level in the serum of lung cancer patients but also identified that elevated SAA level may be a non-invasive biomarker useful for the prediction of lung cancer prognosis.
Treatment assignment may influence outcome of symptomatic patients with AS.